R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 7,172 shares at $42.34 ($304K) on 2021-04-07, disclosed to the SEC on 2021-04-09.
Open-market sale of $304k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.34 | 3,586 | $152K | 50.0% |
| 2 | $42.34 | 3,586 | $152K | 50.0% |
| Total | $42.34 avg | 7,172 | $304K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |